Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.45 |
| ▸ | KMO | O15229 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17280882 | 0.90 | MEN1 (0.41) | PDK2KMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL17280879 | 0.90 | MEN1 (0.41) | PDK2KMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL17427009 | 0.85 | KMT2A (0.41) | PDK2KMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL31517012 | 0.85 | PDK2 (0.49) | PDK2PGRKMT2AMAPTMEN1 | |
| SCHEMBL17416287 | 0.85 | PDK2 (0.49) | PDK2PGRKMT2AMAPTMEN1 | |
| SCHEMBL19009420 | 0.83 | PDK2 (0.48) | PDK2PGRKMT2AMAPTMEN1 | |
| SCHEMBL17326962 | 0.83 | PDK2 (0.61) | PDK2PGR | |
| SCHEMBL10042456 | 0.83 | PDK2 (0.39) | PDK2KMOPLK1PGRKMT2A | |
| SCHEMBL20601887 | 0.83 | PDK2 (0.49) | PDK2PGRKMT2AMAPTMEN1 | |
| SCHEMBL29450659 | 0.83 | PDK2 (0.49) | PDK2KMOPGRMAP4K4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917910-B2 | Organic compound and organic electroluminescent device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917910-B2 | Organic compound and organic electroluminescent device using the same | VDAC1, OR10J3, PIEZO1 | PDK2 1979/4885KMO 1597/4885CYP19A1 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.